跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
F10
首页
药物
F10
F10
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING CHRONIC KIDNEY DISEASE
EP 4754532 A1
申请人: NESTLE SA
优先权: 2023
CN
EP
US
WO
4 件公开
Combine use of pterostilbene and quercetin for the production of cancer treatment medicaments
US 8227510 B2
申请人: ESTRELA ARIQUEL JOSE MARIA
优先权: 2004
EP
US
WO
4 件公开
Methods of inhibiting poxvirus growth
US 8076375 B2
申请人: SEFTON BARTHOLOMEW M
优先权: 2006
US
2 件公开
Uses of 15-benzylidene-14-deoxy-11,12-didehydroandrographolide derivatives in the preparation of antineoplastic drugs
US 9198894 B2
申请人: WU FENGJUAN
优先权: 2010
US
2 件公开
Monoclonal antibody and application thereof in resisting pepper vein mottle virus
CN 118754974 A
申请人: PLANT PROT & QUALITY & SAFETY AGRICULTURAL PROD INST ANHUI ACADEMY AGRICULTURAL SCI
优先权: 2023
CN
2 件公开
NOVEL ANTIBODY MOLECULES AND NUCLEIC ACIDS BINDING TO FUNGAL STRESS PROTEIN HSP90
US 2010113355 A1
申请人: CHENNAMSETTY NARESH
优先权: 2007
US
Recombinant rat myeloma cell NS0-F10 and application thereof
CN 101899416 A
申请人: INST BIOPHYSICS CN ACAD SCI
优先权: 2010
CN
Cinnamoyl sulfonamide compound preparation and applications of cinnamoyl sulfonamide compounds in anti-tumor treatment drugs
CN 102838515 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2011
CN
Preparation of 1,3,4-oxadiazole compounds and application thereof in anticancer treatment drug
CN 103044350 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2011
CN
Hybridoma cell strain and monoclonal antibody of anti-heart-type fatty acid-binding protein generated by same
CN 103045541 A
申请人: UNIV PLA 3RD MILITARY MEDICAL
优先权: 2012
CN
第 1 / 9 页
上一页
下一页
药物
反馈